Flexbumin Injection, Solution
Product Images NDC 0944-0495

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flexbumin (NDC 0944-0495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flexbumin 01

Label for Flexbumin (Albumin Human) injection solution, 5% USP strength, in a 250 mL single-dose container. The product is for intravenous use only and contains 12.5 g albumin stabilized with sodium caprylate and N-acetyltryptophan. Manufactured by Takeda Pharmaceuticals America, Inc. The label includes storage instructions, usage warnings, and a barcode.*

FDA Label Image

Flexbumin 02

Flexbumin 5% USP 250 mL injection solution for infusion, containing Albumin Human. The label indicates two 250 mL single-dose containers, with a concentration of 5% Albumin stabilized with sodium caprylate and N-acetyltryptophan. The product is for intravenous use only, labeled by Takeda Pharmaceuticals America, Inc., with instructions to protect from freezing and store at room temperature not exceeding 25°C (77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.